Clinical Data News
Most Popular Clinical Data Story
Safety fears derail late-stage Amgen cancer trial
Amgen has been dealt a serious blow to its hopes to develop new cancer therapies. Researchers for Amgen and Takeda suspended enrollment in a late-stage trial for motesanib after tracking a higher... Read more...
Latest Headlines
- February 9, 2010
- September 11, 2009
- August 14, 2009
- August 11, 2009
- April 3, 2009
- November 20, 2008
- November 3, 2008
- October 28, 2008
- October 13, 2008
- October 8, 2008
- August 5, 2008
- September 6, 2007
- June 14, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
